BRIEF published on 04/15/2025 at 09:05, 1 year 4 months ago FRIWO Achieves 2024 Targets, Anticipates Growth in 2025 Revenue Growth 2024 Targets E-mobility Strategic Realignment FRIWO
BRIEF published on 04/15/2025 at 09:05, 1 year 4 months ago FRIWO atteint ses objectifs pour 2024 et anticipe une croissance en 2025 Croissance Des Revenus Mobilité Électrique Réalignement Stratégique FRIWO Objectifs 2024
BRIEF published on 04/15/2025 at 09:05, 1 year 4 months ago Exasol AG Extends CEO Jörg Tewes' Contract Early Exasol AG Contract Extension Profitable Growth Leadership Strategy Jörg Tewes
BRIEF published on 04/15/2025 at 09:05, 1 year 4 months ago Exasol AG prolonge le contrat de son PDG Jörg Tewes par anticipation Exasol AG Croissance Rentable Stratégie De Leadership Prolongation De Contrat Jörg Tewes
BRIEF published on 04/15/2025 at 09:05, 1 year 4 months ago Blue Elephant Energy Acquires Majority Stake in Solar215 Acquisition Renewable Energy Battery Storage Blue Elephant Energy Germany Energy Market
BRIEF published on 04/15/2025 at 09:05, 1 year 4 months ago Blue Elephant Energy acquiert une participation majoritaire dans Solar215 Acquisition Énergie Renouvelable Stockage De La Batterie Énergie De L'éléphant Bleu Marché De L'énergie Allemand
BRIEF published on 04/15/2025 at 09:05, 1 year 4 months ago Cyprumed Partners with MSD on Oral Peptide Therapeutics Drug Delivery Technology License Agreement Cyprumed MSD Partnership Oral Peptide Therapeutics
BRIEF published on 04/15/2025 at 09:05, 1 year 4 months ago Cyprumed s'associe à MSD pour développer des thérapies peptidiques orales Technologie D'administration De Médicaments Accord De Licence Cyprumé Partenariat MSD Thérapies Peptidiques Orales
BRIEF published on 04/15/2025 at 09:05, 1 year 4 months ago EMERAM Demonstrates Resilience with Strategic Investments and Exit in 2024 Digital Transformation Private Equity Market Growth Investments Financial Strategy
BRIEF published on 04/15/2025 at 09:05, 1 year 4 months ago EMERAM démontre sa résilience avec des investissements stratégiques et une sortie en 2024 Transformation Numérique Investissements Stratégie Financière Capital-investissement Croissance Du Marché
Published on 09/11/2026 at 23:00, 35 minutes ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 1 hour 30 minutes ago Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 2 hours 10 minutes ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 6 hours 35 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/11/2026 at 17:00, 6 hours 35 minutes ago Critical Elements sélectionné pour inclusion dans le prospectus du sommet Canadien de l'investissement, mettant le projet en valeur auprès d'investisseurs mondiaux de premier plan
Published on 09/11/2026 at 22:15, 1 hour 20 minutes ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 1 hour 25 minutes ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 3 hours 50 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 5 hours 20 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 07:00, 16 hours 35 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 16 hours 35 minutes ago Transparency notification by Baltisse Group
Published on 09/11/2026 at 07:00, 16 hours 35 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 16 hours 35 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 4 hours ago Availability of the 2026 Interim Financial Report
